Skip to content

Restore Claims Characterization Study

Restore Claims Characterization Study

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00200122
Enrollment
100
Registered
2005-09-20
Start date
2005-01-31
Completion date
2007-08-31
Last updated
2009-01-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Refractory Pain Associated With Failed Back Surgery Syndrome, Epidural Fibrosis, Peripheral Causalgia, Complex Regional Pain Syndrome

Brief summary

The purpose of this study is to characterize the pain coverage capability of the RESTORE spinal cord stimulation (SCS) and assess health outcomes.

Interventions

DEVICESpinal Cord Stimulation

Sponsors

MedtronicNeuro
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
SINGLE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Has chronic refractory pain associated with one of the conditions currently approved for spinal cord stimulation as follows: Failed Back Syndrome, Degenerative Disk Disease (DDD), Herniated Disk pain refractory to conservative and surgical interventions, Peripheral Causalgia, Complex Regional Pain Syndrome (CRPS) or Reflex Sympathetic Dystrophy (RSD). * Primary pain in the lower half of the body.

Exclusion criteria

* Requires, or will in the future, diathermy treatments. * Had implanted spinal cord stimulation system within the last six months.

Design outcomes

Primary

MeasureTime frame
The primary endpoint is to assesses the pain coverage capability of the RESTORE SCS system.

Secondary

MeasureTime frame
Secondary outcome measures include pain relief, quality of life, function, patient and physician acceptance.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026